Qinghai Spring Medicinal Resources Technology , Ltd. Receivables

Qinghai Spring Medicinal Resources Technology , Ltd. (600381.SS) currently reports a receivables of $67M as of June 2026. That compares with $63M in the prior-year period — up 6.5% year over year. Use the charts on this page to explore Qinghai Spring Medicinal Resources Technology , Ltd.'s receivables history and peer comparisons.

Qinghai Spring Medicinal Resources Technology , Ltd.'s receivables increased from $63M to $67M — a 6.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Qinghai Spring Medicinal Resources Technology , Ltd. reported $67M in receivables as of June 2026. That compares with $63M in the prior-year period — up 6.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $67M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Qinghai Spring Medicinal Resources Technology , Ltd., and consider following 600381.SS for alerts when major investors trade the stock.